NEU

NEUREN PHARMACEUT.

• ASX·3d ago

  NNZ-2591 PMS Phase 2 trial published in Neurology Genetics

• ASX·12/21/2025 22:50

  Health Canada approves Clinical Trial Application for Koala

• The Motley Fool·12/15/2025 03:22

  Why 4DMedical, EOS, Gorilla Gold, and Neuren shares are racing higher today

• The Motley Fool·12/15/2025 00:02

  This ASX 200 stock is charging higher on FDA approval news

• ASX·12/14/2025 22:07

  FDA approves DAYBUE STIX (trofinetide), powder formulation

• ASX·12/08/2025 23:39

  One-month administrative delay to FDA meeting for HIE

• ASX·11/24/2025 06:44

  Application for quotation of securities - NEU

• The Motley Fool·11/11/2025 02:50

  Macquarie predicts 12% upside for this ASX 200 healthcare stock

• ASX·11/09/2025 21:48

  Investor Presentation, 10 November 2025

• The Motley Fool·11/07/2025 04:02

  Brokers name 3 ASX shares to buy today

• The Motley Fool·11/06/2025 21:58

  Down 10% in a day! Why this ASX stock could now deliver market-beating returns

• ASX·11/06/2025 00:00

  NEUREN PHARMACEUTICALS LIMITED Press

• The Motley Fool·10/30/2025 04:57

  Bell Potter just upgraded the target price on ASX healthcare stock

• Dow Jones·10/28/2025 22:47

  *Neuren Pharmaceuticals Target Price Raised 14% to A$25.00/Share by Bell Potter>NEU.AU

• The Motley Fool·10/20/2025 02:46

  Which biotech's shares have hit a 12-month high on good news from the FDA?